Serum levels of trace elements in patients with prostate cancer
| dc.contributor.author | Kaba M. | |
| dc.contributor.author | Pirincci N. | |
| dc.contributor.author | Yuksel M.B. | |
| dc.contributor.author | Gecit I. | |
| dc.contributor.author | Gunes M. | |
| dc.contributor.author | Ozveren H. | |
| dc.contributor.author | Eren H. | |
| dc.contributor.author | Demir H. | |
| dc.date.accessioned | 2025-04-10T11:13:24Z | |
| dc.date.available | 2025-04-10T11:13:24Z | |
| dc.date.issued | 2014 | |
| dc.description.abstract | Background: Trace elements are major components of biological structures; however, excessive levels of these elements can be toxic. Materials and Methods: In the present study, serum levels of trace elements were measured in 30 patients with newly diagnosed as prostate cancer and 32 healthy volunteer by using furnace atomic absorption spectrophotometry. Results: It was found that there was an increase in serum levels of Co, Cu, Mg and Pb (p<0.05), whereas a decrease in serum levels of Fe, Mn, and Zn levels in patients with prostate cancer (p<0.05). Conclusions: These changes may be important in the pathogenesis of prostate cancers; however, further prospective studies are needed to identify relationships between prostate cancer and trace elements. | |
| dc.identifier.DOI-ID | 10.7314/APJCP.2014.15.6.2625 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14701/49877 | |
| dc.publisher | Asian Pacific Organization for Cancer Prevention | |
| dc.title | Serum levels of trace elements in patients with prostate cancer | |
| dc.type | Article |